Guardant Health Statistics
Total Valuation
Guardant Health has a market cap or net worth of $12.96 billion. The enterprise value is $13.71 billion.
Important Dates
The next estimated earnings date is Thursday, February 19, 2026, after market close.
| Earnings Date | Feb 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Guardant Health has 128.84 million shares outstanding. The number of shares has increased by 2.22% in one year.
| Current Share Class | 128.84M |
| Shares Outstanding | 128.84M |
| Shares Change (YoY) | +2.22% |
| Shares Change (QoQ) | +0.56% |
| Owned by Insiders (%) | 3.99% |
| Owned by Institutions (%) | 96.48% |
| Float | 123.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.84 |
| Forward PS | 10.87 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 15.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.50
| Current Ratio | 3.50 |
| Quick Ratio | 2.94 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -131.57 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -19.64% |
| Return on Invested Capital (ROIC) | -24.56% |
| Return on Capital Employed (ROCE) | -42.54% |
| Revenue Per Employee | $446,595 |
| Profits Per Employee | -$197,323 |
| Employee Count | 2,021 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 4.02 |
Taxes
In the past 12 months, Guardant Health has paid $1.18 million in taxes.
| Income Tax | 1.18M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +230.49% in the last 52 weeks. The beta is 1.59, so Guardant Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.59 |
| 52-Week Price Change | +230.49% |
| 50-Day Moving Average | 95.86 |
| 200-Day Moving Average | 61.84 |
| Relative Strength Index (RSI) | 51.29 |
| Average Volume (20 Days) | 1,812,929 |
Short Selling Information
The latest short interest is 9.85 million, so 7.65% of the outstanding shares have been sold short.
| Short Interest | 9.85M |
| Short Previous Month | 9.25M |
| Short % of Shares Out | 7.65% |
| Short % of Float | 7.96% |
| Short Ratio (days to cover) | 4.36 |
Income Statement
In the last 12 months, Guardant Health had revenue of $902.57 million and -$398.79 million in losses. Loss per share was -$3.21.
| Revenue | 902.57M |
| Gross Profit | 575.46M |
| Operating Income | -442.33M |
| Pretax Income | -397.61M |
| Net Income | -398.79M |
| EBITDA | -402.19M |
| EBIT | -442.33M |
| Loss Per Share | -$3.21 |
Full Income StatementBalance Sheet
The company has $580.01 million in cash and $1.33 billion in debt, giving a net cash position of -$746.36 million or -$5.79 per share.
| Cash & Cash Equivalents | 580.01M |
| Total Debt | 1.33B |
| Net Cash | -746.36M |
| Net Cash Per Share | -$5.79 |
| Equity (Book Value) | -354.47M |
| Book Value Per Share | -2.84 |
| Working Capital | 591.97M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$222.90 million and capital expenditures -$39.33 million, giving a free cash flow of -$262.23 million.
| Operating Cash Flow | -222.90M |
| Capital Expenditures | -39.33M |
| Free Cash Flow | -262.23M |
| FCF Per Share | -$2.04 |
Full Cash Flow StatementMargins
Gross margin is 63.76%, with operating and profit margins of -49.01% and -44.18%.
| Gross Margin | 63.76% |
| Operating Margin | -49.01% |
| Pretax Margin | -44.05% |
| Profit Margin | -44.18% |
| EBITDA Margin | -44.56% |
| EBIT Margin | -49.01% |
| FCF Margin | n/a |
Dividends & Yields
Guardant Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.22% |
| Shareholder Yield | -2.22% |
| Earnings Yield | -3.08% |
| FCF Yield | -2.02% |
Dividend DetailsAnalyst Forecast
The average price target for Guardant Health is $96.48, which is -4.10% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $96.48 |
| Price Target Difference | -4.10% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 21 |
| Revenue Growth Forecast (5Y) | 26.46% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Guardant Health has an Altman Z-Score of -1.08 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.08 |
| Piotroski F-Score | 4 |
